Leelyn Smith’s Pfizer PFE Stock Holding History

Leelyn Smith’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.97M	Buy	123,384 +5,306	+4%	+$139K	0.36%	81
2026 Q1	$3.32M	Buy	118,078 +6,168	+6%	+$164K	0.47%	62
2025 Q4	$2.79M	Buy	111,910 +4,965	+5%	+$125K	0.4%	68
2025 Q3	$2.72M	Buy	106,945 +7,608	+8%	+$188K	0.41%	71
2025 Q2	$2.41M	Buy	99,337 +5,729	+6%	+$134K	0.4%	74
2025 Q1	$2.37M	Buy	93,608 +5,841	+7%	+$153K	0.42%	69
2024 Q4	$2.33M	Buy	87,767 +5,311	+6%	+$144K	0.41%	71
2024 Q3	$2.39M	Buy	82,456 +5,382	+7%	+$157K	0.43%	70
2024 Q2	$2.16M	Buy	77,074 +8,902	+13%	+$245K	0.42%	66
2024 Q1	$1.89M	Buy	68,172 +4,978	+8%	+$138K	0.38%	75
2023 Q4	$1.82M	Buy	63,194 +5,265	+9%	+$159K	0.4%	66
2023 Q3	$1.92M	Buy	57,929 +4,347	+8%	+$154K	0.47%	62
2023 Q2	$1.97M	Sell	53,582 -3,707	-6%	-$144K	0.47%	60
2023 Q1	$2.34M	Buy	57,289 +1,461	+3%	+$63.1K	0.6%	57
2022 Q4	$2.86M	Buy	55,828 +4,639	+9%	+$222K	0.79%	36
2022 Q3	$2.24M	Sell	51,189 -53,753	-51%	-$2.61M	0.77%	35
2022 Q2	$5.5M	Buy	104,942 +53,683	+105%	+$2.74M	1.43%	15
2022 Q1	$2.65M	Buy	51,259 +1,017	+2%	+$52.8K	0.69%	42
2021 Q4	$2.97M	Sell	50,242 -1,952	-4%	-$96.7K	0.79%	31
2021 Q3	$2.25M	Buy	52,194 +485	+0.9%	+$21.5K	0.65%	44
2021 Q2	$2.02M	Buy	51,709 +707	+1%	+$27.5K	0.6%	50
2021 Q1	$1.85M	Buy	51,002 +3,978	+8%	+$141K	0.55%	55
2020 Q4	$1.73M	Buy	47,024 +206	+0.4%	+$7.56K	0.55%	55
2020 Q3	$1.63M	Buy	46,818 +652	+1%	+$22.9K	0.58%	49
2020 Q2	$1.43M	Buy	46,166 +97	+0.2%	+$3.29K	0.59%	46
2020 Q1	$1.43M	Buy	46,069 +6,214	+16%	+$212K	0.76%	34
2019 Q4	$1.48K	Buy	+39,855	New	+$1.42M	0.71%	37

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Leelyn Smith's PFE Position: Q2 2026 in Review

Leelyn Smith increased its Pfizer (PFE) stake by 4.5% in Q2 2026, buying an estimated $139K and bringing the position to 123,384 shares worth $2.97M. The position accounts for 0.36% of the portfolio, ranked #81.

Leelyn Smith first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.5M in Q2 2022. 1,342 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Leelyn Smith held 123,384 shares of Pfizer worth $2.97M as of Q2 2026.
Leelyn Smith bought 5,306 Pfizer shares in Q2 2026, an estimated $139K.
Pfizer made up 0.36% of Leelyn Smith's portfolio in Q2 2026, its #81 holding.
Leelyn Smith first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
Leelyn Smith's Pfizer position peaked at $5.5M in Q2 2022.
1,342 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.